Literature DB >> 22282102

[Advanced bladder cancer in elderly patients. Prognostic outcomes and therapeutic strategies].

M Rink1, F K Chun, T F Chromecki, H Fajkovic, R Dahlem, M Fisch, S F Shariat.   

Abstract

INTRODUCTION: Age is suggested to be the greatest single risk factor for developing urothelial carcinoma of the bladder (UCB). This review presents an overview of the incidence, prognosis, surgical and medical therapy of UCB in elderly patients (> 65 years).
RESULTS: Elderly patients have an approximate 11-fold increase in the incidence and a 15-fold increase in UCB mortality when compared to younger individuals. However, adequate surgical or medical treatment is less often or delayed offered to elderly patients. In properly selected cases, similar surgical outcomes and complication rates are reported in elderly patients, regardless of the type of urinary diversion. Application of perioperative systemic chemotherapy is dependent on physiologic deterioration and comorbidities. An adequate, restrictive case selection and early proactive postoperative rehabilitation are important factors to achieve good results.
CONCLUSIONS: In adequately selected elderly patients, radical cystectomy and urinary diversion as well as systemic chemotherapy are feasible, safe and efficacious treatment options for advanced UCB.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22282102     DOI: 10.1007/s00120-011-2769-2

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  64 in total

1.  Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy.

Authors:  Matthew E Nielsen; Shahrokh F Shariat; Pierre I Karakiewicz; Yair Lotan; Craig G Rogers; Gilad E Amiel; Patrick J Bastian; Amnon Vazina; Amit Gupta; Seth P Lerner; Arthur I Sagalowsky; Mark P Schoenberg; Ganesh S Palapattu
Journal:  Eur Urol       Date:  2006-11-13       Impact factor: 20.096

2.  Impact of hospital and surgeon volume on in-hospital mortality from radical cystectomy: data from the health care utilization project.

Authors:  Badrinath R Konety; Vibhu Dhawan; Veerasathpurush Allareddy; Sue A Joslyn
Journal:  J Urol       Date:  2005-05       Impact factor: 7.450

3.  Identifying risk factors for potentially avoidable complications following radical cystectomy.

Authors:  Brent K Hollenbeck; David C Miller; David Taub; Rodney L Dunn; Shukri F Khuri; William G Henderson; James E Montie; Willie Underwood; John T Wei
Journal:  J Urol       Date:  2005-10       Impact factor: 7.450

Review 4.  Assessing the nutritional status of the elderly: The Mini Nutritional Assessment as part of the geriatric evaluation.

Authors:  Y Guigoz; B Vellas; P J Garry
Journal:  Nutr Rev       Date:  1996-01       Impact factor: 7.110

Review 5.  Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG).

Authors:  Martine Extermann; Matti Aapro; Roberto Bernabei; Harvey Jay Cohen; Jean-Pierre Droz; Stuart Lichtman; Vincent Mor; Silvio Monfardini; Lazzaro Repetto; Liv Sørbye; Eva Topinkova
Journal:  Crit Rev Oncol Hematol       Date:  2005-09       Impact factor: 6.312

Review 6.  [Quality of life after radical cystectomy - an overview and analysis of a contemporary series].

Authors:  T Severin; P Bub; D Jocham; Ingo Kausch
Journal:  Aktuelle Urol       Date:  2010-06-01       Impact factor: 0.658

7.  Late age (85 years or older) peak incidence of bladder cancer.

Authors:  Matthew Schultzel; Sidney L Saltzstein; Tracy M Downs; Suzuho Shimasaki; Catherine Sanders; Georgia Robins Sadler
Journal:  J Urol       Date:  2008-03-04       Impact factor: 7.450

8.  Morbidity and quality of life in elderly patients receiving ileal conduit or orthotopic neobladder after radical cystectomy for invasive bladder cancer.

Authors:  Filippo Sogni; Maurizio Brausi; Bruno Frea; Carlo Martinengo; Fabrizio Faggiano; Alessandro Tizzani; Paolo Gontero
Journal:  Urology       Date:  2008-03-20       Impact factor: 2.649

9.  Benefit of radical cystectomy in the elderly patient with significant co-morbidities.

Authors:  Scott B Farnham; Michael S Cookson; Gregory Alberts; Joseph A Smith; Sam S Chang
Journal:  Urol Oncol       Date:  2004 May-Jun       Impact factor: 3.498

10.  Introduction of an enhanced recovery protocol for radical cystectomy.

Authors:  Nimalan Arumainayagam; John McGrath; Kieran P Jefferson; David A Gillatt
Journal:  BJU Int       Date:  2008-01-08       Impact factor: 5.588

View more
  10 in total

Review 1.  [Upper tract urothelial carcinoma. An update on clinical and pathological prognostic factors].

Authors:  M Rink; M Adam; J Hansen; F K Chun; S A Ahyai; M Remzi; T Schlomm; O Engel; R Heuer; C Eichelberg; M Fisch; R Dahlem; S F Shariat
Journal:  Urologe A       Date:  2012-09       Impact factor: 0.639

Review 2.  Contemporary gender-specific outcomes in Germany after radical cystectomy for bladder cancer.

Authors:  Marianne Schmid; Shahrokh F Shariat; Armin Soave; Oliver Engel; Margit Fisch; Michael Rink
Journal:  Curr Urol Rep       Date:  2014-06       Impact factor: 3.092

3.  [Radical cystectomy and ileal neobladder reconstruction in elderly female patients over 70 years old: morbidity, functional and oncological long-term results].

Authors:  F Jentzmik; M Schrader; R de Petriconi; R Hefty; J Doetterl; A Eickhoff; A J Schrader
Journal:  Urologe A       Date:  2012-10       Impact factor: 0.639

Review 4.  Lymph node dissection during radical cystectomy for bladder cancer treatment: considerations on relevance and extent.

Authors:  Lars Weisbach; Roland Dahlem; Giuseppe Simone; Jens Hansen; Armin Soave; Oliver Engel; Felix K Chun; Shahrokh F Shariat; Margit Fisch; Michael Rink
Journal:  Int Urol Nephrol       Date:  2013-07-25       Impact factor: 2.370

5.  Patient, provider, and hospital factors associated with oral anti-neoplastic agent initiation and adherence in older patients with metastatic renal cell carcinoma.

Authors:  Deborah R Kaye; Lauren E Wilson; Melissa A Greiner; Lisa P Spees; Jessica E Pritchard; Tian Zhang; Craig E Pollack; Daniel George; Charles D Scales; Chris D Baggett; Cary P Gross; Michael S Leapman; Stephanie B Wheeler; Michaela A Dinan
Journal:  J Geriatr Oncol       Date:  2022-02-04       Impact factor: 3.929

Review 6.  [Cystectomy in the elderly patient].

Authors:  G Bartsch; K Gust; S Vallo; C Bartsch; I Tsaur; J Mani; A Haferkamp
Journal:  Urologe A       Date:  2013-06       Impact factor: 0.639

7.  [Cost-effectiveness analysis of blue light cystoscopy with hexylaminolevulinate in transurethral resection of the bladder].

Authors:  G Gakis; B Volkmer; B Qvick; F Marteau; A Stenzl
Journal:  Urologe A       Date:  2019-01       Impact factor: 0.639

Review 8.  Female with bladder cancer: what and why is there a difference?

Authors:  Phillip Marks; Armin Soave; Shahrokh F Shariat; Harun Fajkovic; Margit Fisch; Michael Rink
Journal:  Transl Androl Urol       Date:  2016-10

9.  Costs of Cancer Care Across the Disease Continuum.

Authors:  Deborah R Kaye; Hye Sung Min; Lindsey A Herrel; James M Dupree; Chad Ellimoottil; David C Miller
Journal:  Oncologist       Date:  2018-03-22

10.  Oxidative status and lipofuscin accumulation in urothelial cells of bladder in aging mice.

Authors:  Martina Perše; Rade Injac; Andreja Erman
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.